Skip to content

The Reliability and Validity of the Turkish Version of the LSQ

The Reliability and Validity of the Turkish Version of the Lipedema Screening Questionnaire

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07061808
Acronym
LSQ
Enrollment
59
Registered
2025-07-11
Start date
2022-10-20
Completion date
2023-10-25
Last updated
2025-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lipedema, Women

Keywords

lipedema, validity, reliability, Turkish adaptation

Brief summary

Abstract Background/ Aim: The aim of this study was to investigate the reliability and validity of the Turkish version of the Lipedema Screening Questionnaire (T-LSQ). Method: The study involved 59 female volunteers diagnosed with lipedema by a cardiovascular surgeon. Key demographics such as age, onset age, lipedema types and stages, clinical features, and BMI were recorded. The Turkish adaptation of the LSQ was performed in accordance with the protocol of Beaton. Confirmatory factor analysis was performed for structural validity. For concurrent validity, T- LSQ, the Lower Extremity Functional Scale (LEFS), the Lymphedema Life Impact Scale (LLIS), and the Lymphoedema Functioning, Disability and Health Quastionnaire for Lower Extremity Lymphedema (Lymph-ICF-LL) were applied and the correlation between the scale responses was analyzed. Test-retest and internal consistency reliability were performed.

Interventions

DIAGNOSTIC_TESTLipedema Screening Questionnaire

The Lipoedema screening questionnaire (LSQ) is a practical tool that can be applied quickly and easily and is used to identify patients with lipoedema during history taking and physical examination.

Sponsors

Gazi University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * had no communication cognitive and mental problem * participant in Turkish

Exclusion criteria

* Patients with diagnoses of renal and heart failure * individuals with history of lower extremity surgery * individuals with severe arterial venous disease involving the lower extremity * individuals with active cancer disease or metastasis * individuals with severe acute infective disease

Design outcomes

Primary

MeasureTime frameDescription
The Validity and Reliability of Turkish version of the Lipedema Screening Questionnaireat 10-day intervals.The Validity and Reliability of Turkish version of the Lipedema Screening Questionnaire: For validity, T-LSQ, Lower Extremity Functional Scale (LEFS), Lymphedema Life Impact Scale (LLIS) and Lymphedema Function, Disability and Health Questionnaire for Lower Extremity Lymphedema (Lymph-ICF-LL) were applied and correlation analysis between scale responses will be done. The LSQ questionnaire, whose reliability we measured, was applied at the beginning of the study and again after 10 days.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026